These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9374514)

  • 81. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H; Tarnok J; Parks WP
    J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation.
    Kähne T; Kröning H; Thiel U; Ulmer AJ; Flad HD; Ansorge S
    Cell Immunol; 1996 May; 170(1):63-70. PubMed ID: 8660800
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism.
    Engel M; Hoffmann T; Wagner L; Wermann M; Heiser U; Kiefersauer R; Huber R; Bode W; Demuth HU; Brandstetter H
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5063-8. PubMed ID: 12690074
    [TBL] [Abstract][Full Text] [Related]  

  • 84. How Tat targets TAR: structure of the BIV peptide-RNA complex.
    Greenbaum NL
    Structure; 1996 Jan; 4(1):5-9. PubMed ID: 8805518
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
    Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
    J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
    Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
    J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
    Zhao H; Li J; Jiang L
    Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.
    Ziegler A; Seelig J
    Biophys J; 2004 Jan; 86(1 Pt 1):254-63. PubMed ID: 14695267
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Faust J; Neubert K; Ansorge S
    Immunology; 1997 Jul; 91(3):354-60. PubMed ID: 9301523
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset.
    Kubota T; Iizuka H; Bachovchin WW; Stollar BD
    Clin Exp Immunol; 1994 May; 96(2):292-6. PubMed ID: 7910536
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents.
    Péloponèse JM; Collette Y; Grégoire C; Bailly C; Campèse D; Meurs EF; Olive D; Loret EP
    J Biol Chem; 1999 Apr; 274(17):11473-8. PubMed ID: 10206951
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
    Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
    Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
    [TBL] [Abstract][Full Text] [Related]  

  • 96. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
    Preller V; Gerber A; Wrenger S; Togni M; Marguet D; Tadje J; Lendeckel U; Röcken C; Faust J; Neubert K; Schraven B; Martin R; Ansorge S; Brocke S; Reinhold D
    J Immunol; 2007 Apr; 178(7):4632-40. PubMed ID: 17372022
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Conformational heterogeneity in two regions of TAT results in structural variations of this protein as a function of HIV-1 isolates.
    Gregoire CJ; Loret EP
    J Biol Chem; 1996 Sep; 271(37):22641-6. PubMed ID: 8798435
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility.
    Govender Y; Shalekoff S; Ebrahim O; Waja Z; Chaisson RE; Martinson N; Tiemessen CT
    Clin Immunol; 2021 Sep; 230():108824. PubMed ID: 34391936
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparative nucleic acid chaperone properties of the nucleocapsid protein NCp7 and Tat protein of HIV-1.
    Godet J; Boudier C; Humbert N; Ivanyi-Nagy R; Darlix JL; Mély Y
    Virus Res; 2012 Nov; 169(2):349-60. PubMed ID: 22743066
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells.
    Tansi FL; Blanchard V; Berger M; Tauber R; Reutter W; Fan H
    Virol J; 2010 Oct; 7():267. PubMed ID: 20942971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.